Key Insights from the JP Morgan 2026 Healthcare Conference | LSC NJ
At the February 12, 2026 meeting of the Life Science Collaborative of New Jersey (LSC NJ), Peter Jaslow of Ballard Spahr LLP and John Pennett of EisnerAmper led a strategic discussion on the most important takeaways from the JP Morgan 2026 Healthcare Conference. The session examined biotech financing trends, healthcare capital markets activity, life sciences […]